BXP
47
-7
DRI
54
-2
AMGN
44
-6
WY
53
-3
TSN
47
9
AEE
63
-3
L
59
-3
HSY
40
3
CPB
22
-3
DVN
25
-3
ABT
60
-2
DOW
28
-2
SE
65
11
TGT
52
2
KMB
28
-2
AXP
69
-2
NRG
52
-2
DG
10
-2
MMM
37
-7
PG
48
-2
BXP
47
-7
DRI
54
-2
AMGN
44
-6
WY
53
-3
TSN
47
9
AEE
63
-3
L
59
-3
HSY
40
3
CPB
22
-3
DVN
25
-3
ABT
60
-2
DOW
28
-2
SE
65
11
TGT
52
2
KMB
28
-2
AXP
69
-2
NRG
52
-2
DG
10
-2
MMM
37
-7
PG
48
-2
Financhill
Back

Matinas BioPharma Holdings Quote, Financials, Valuation and Earnings

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
0.71
Seasonality Move:
10.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Matinas BioPharma Holdings Price Quote

$0.71
-0.04 (-4.83%)
(Updated: November 13, 2024 at 5:55 PM ET)

Matinas BioPharma Holdings Key Stats

Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell
Day range:
$0.69 - $0.97
52-week range:
$0.50 - $21.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.78
P/B ratio:
0.2%
Volume:
442.2K
Avg. volume:
365.9K
1-year change:
-93%
Market cap:
$3.7M
Revenue:
$1.1M
EPS:
$-5.5

How Much Does Matinas BioPharma Holdings Make?

Data Unavailable

Is Matinas BioPharma Holdings Growing As A Company?

Data Unavailable

Matinas BioPharma Holdings Stock Price Performance

What Is Matinas BioPharma Holdings 52-Week High & Low?

Matinas BioPharma Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Matinas BioPharma Holdings?

Is Matinas BioPharma Holdings Cash Flow Positive?

  • What Is MTNB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.9M
  • What Is Matinas BioPharma Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.2M
  • What Is Matinas BioPharma Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $3.1M

Matinas BioPharma Holdings Return On Invested Capital

Data Unavailable

Matinas BioPharma Holdings Earnings Date & Stock Price

Matinas BioPharma Holdings Competitors

Matinas BioPharma Holdings Dividend Yield

Matinas BioPharma Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 98%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 3921.45%

Major Shareholders

  • How many MTNB shares are owned by institutional investors?
    37.8M MTNB shares are owned by institutional investors
  • How many MTNB shares are owned by insiders?
    11.3M MTNB shares are owned by insiders